Artivion (AORT) vs Tandem Diabetes Care (TNDM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Tandem Diabetes Care (TNDM) has outperformed Artivion (AORT) over the past year, gaining 9.1% versus a loss of 46.7%. Over five years, AORT leads with a +1.2% price change compared with -87.4% for TNDM. Tandem Diabetes Care is the larger company by market cap ($1.08 billion vs $1.03 billion), about 1.0 times the size.
On valuation, Artivion trades at a lower forward P/E (28.3x vs 97.6x for Tandem Diabetes Care).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AORT | TNDM |
|---|---|---|
| Share price | $21.20 | $15.52 |
| Market cap | $1.03B | $1.08B |
| 1-day change | -1.92% | -2.02% |
| YTD return | -52.62% | -27.93% |
| 1-year return | -46.66% | +9.09% |
| 5-year return | +1.17% | -87.36% |
| Forward P/E | 28.32 | 97.63 |
| EPS (TTM) | $-0.07 | $-0.91 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $48.25 | $29.65 |
| 52-week low | $19.16 | $12.26 |
| Distance from 52-week high | -56.07% | -47.66% |
| Analyst consensus | none | buy |
| Avg. price target upside | +98.87% | +79.51% |
| Average volume | 634.11K | 1.99M |
| Shares outstanding | 48.76M | 69.58M |
| Employees | 1,800 | 2,500 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TNDM has outperformed AORT by 55.7 percentage points over the past year.
About Artivion
AORT stock →Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide.
Health Care · Medical/Dental Instruments · 1,800 employees
About Tandem Diabetes Care
TNDM stock →Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.
Health Care · Medical/Dental Instruments · 2,500 employees
AORT vs TNDM FAQ
Which is bigger, Artivion or Tandem Diabetes Care?
Tandem Diabetes Care (TNDM) is larger, with a market capitalization of $1.08B compared with $1.03B for Artivion (AORT).
Which stock has performed better over the past year, AORT or TNDM?
TNDM returned +9.09% over the past 12 months, compared with -46.66% for AORT (price return, excluding dividends). Past performance does not predict future results.
Are Artivion and Tandem Diabetes Care in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.